Case Study: Second Genome (microbiome therapeutics company) achieves accelerated partner acquisition and measurable ROI with CIENCE, Inc.

How CIENCE Accelerated A Clinical Stage Company's Sales WIth Customized Outreach

Second Genome, a clinical-stage microbiome company focused on translating microbiome research into therapeutic targets, needed to accelerate partner and client acquisition across academia, pharma, and biotech for its complex proprietary drug-discovery platform. Because effective outreach required deep biotech subject-matter familiarity and targeted contact with specific research roles, Second Genome engaged CIENCE, Inc. for sales development — an SDR-led outbound lead-generation and dedicated-team model to research ideal client profiles and run proactive prospecting.

CIENCE, Inc. performed discovery, built ICPs, compiled contact data, and executed personalized outreach campaigns integrated into Second Genome’s email and calendar systems, supported by a dedicated customer success manager and weekly optimization meetings. The effort set meetings with professors, investigators, directors and pharma leaders, expanded Second Genome’s reach to new clients and partners, and delivered clear ROI, with CIENCE, Inc. earning five-star scores for scheduling, cost, quality and NPS.

Second Genome

Take Ogawa

Director of Business Development